WO2018052243A1 - Sonde fluorescente destinée à la détection de sulfure d'hydrogène et procédé de préparation de ladite sonde fluorescente - Google Patents
Sonde fluorescente destinée à la détection de sulfure d'hydrogène et procédé de préparation de ladite sonde fluorescente Download PDFInfo
- Publication number
- WO2018052243A1 WO2018052243A1 PCT/KR2017/010046 KR2017010046W WO2018052243A1 WO 2018052243 A1 WO2018052243 A1 WO 2018052243A1 KR 2017010046 W KR2017010046 W KR 2017010046W WO 2018052243 A1 WO2018052243 A1 WO 2018052243A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen sulfide
- formula
- compound represented
- fluorescent probe
- fluorescence
- Prior art date
Links
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 title claims abstract description 75
- 229910000037 hydrogen sulfide Inorganic materials 0.000 title claims abstract description 68
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 12
- 238000001727 in vivo Methods 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 69
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 39
- 239000000126 substance Substances 0.000 claims description 33
- 238000001514 detection method Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 9
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- AXKGIPZJYUNAIW-UHFFFAOYSA-N (4-aminophenyl)methanol Chemical compound NC1=CC=C(CO)C=C1 AXKGIPZJYUNAIW-UHFFFAOYSA-N 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 3
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- IRPKBYJYVJOQHQ-UHFFFAOYSA-M (2e)-2-[(2e)-2-[2-chloro-3-[(e)-2-(3,3-dimethyl-1-propylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-propylindole;iodide Chemical compound [I-].CC1(C)C2=CC=CC=C2N(CCC)\C1=C\C=C/1C(Cl)=C(\C=C/C=2C(C3=CC=CC=C3[N+]=2CCC)(C)C)CCC\1 IRPKBYJYVJOQHQ-UHFFFAOYSA-M 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- QZTKDVCDBIDYMD-UHFFFAOYSA-N 2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid Chemical compound NC(=O)CN(CC(O)=O)CC(O)=O QZTKDVCDBIDYMD-UHFFFAOYSA-N 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011503 in vivo imaging Methods 0.000 description 2
- 229960004657 indocyanine green Drugs 0.000 description 2
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229960003299 ketamine Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 2
- 229960001600 xylazine Drugs 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- QHQZEEGNGSZBOL-UHFFFAOYSA-N 2-(aminomethyl)-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(CO)(CO)CO QHQZEEGNGSZBOL-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- -1 3,3-dimethyl-1-propylindolium iodine Chemical compound 0.000 description 1
- JQVAPEJNIZULEK-UHFFFAOYSA-N 4-chlorobenzene-1,3-diol Chemical compound OC1=CC=C(Cl)C(O)=C1 JQVAPEJNIZULEK-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102100034976 Cystathionine beta-synthase Human genes 0.000 description 1
- 108010073644 Cystathionine beta-synthase Proteins 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- FFFHZYDWPBMWHY-UHFFFAOYSA-N HOMOCYSTEINE Chemical compound OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- JMMCYSCEKRWYEJ-UHFFFAOYSA-M chembl1627016 Chemical compound [Na+].[Na+].[O-]N=[N+]([O-])[O-] JMMCYSCEKRWYEJ-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical group P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 150000003459 sulfonic acid esters Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical class [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
- G01N21/474—Details of optical heads therefor, e.g. using optical fibres
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
- G01N33/0009—General constructional details of gas analysers, e.g. portable test equipment
- G01N33/0027—General constructional details of gas analysers, e.g. portable test equipment concerning the detector
- G01N33/0036—General constructional details of gas analysers, e.g. portable test equipment concerning the detector specially adapted to detect a particular component
- G01N33/0044—Sulphides, e.g. H2S
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
- G01N2021/4764—Special kinds of physical applications
- G01N2021/4766—Sample containing fluorescent brighteners
Definitions
- the present invention relates to a fluorescent probe for detecting hydrogen sulfide represented by the following formula (1) and a preparation method thereof.
- Hydrogen sulfide is a newly recognized messenger, such as cystathinone- ⁇ -lyase (CSE) and cystathionine- ⁇ -synthase (CBS). It is synthesized in mammalian tissue from cysteine and homocysteine through the activity of enzymes.
- CSE cystathinone- ⁇ -lyase
- CBS cystathionine- ⁇ -synthase
- Korean Patent No. 1,404,369 discloses a real-time biosignal measuring apparatus for cardiac ischemia and reperfusion having a hydrogen sulfide sensor for detecting hydrogen sulfide concentration in real time.
- the concentration of hydrogen sulfide in plasma of human blood is known to be 50-100 ⁇ m, so if the concentration level of hydrogen sulfide can be detected quantitatively, Down syndrome, Alzheimer's disease, diabetes and It is possible to diagnose diseases such as cirrhosis.
- H 2 S hydrogen sulfide
- an object of the present invention is to provide a fluorescent probe that can detect hydrogen sulfide (H 2 S) using a non-invasive image in vivo and its manufacturing method.
- the hydrogen sulfide detection fluorescent probe is characterized by the following formula (1).
- the hydrogen sulfide detection fluorescent probe is characterized in that it reacts with hydrogen sulfide in the living body to vary in fluorescence at 550 to 680 nm and 695 to 770 nm.
- a method for producing a fluorescent sulfide probe for detecting hydrogen sulfide includes the steps of preparing a compound represented by Chemical Formula 3 by reacting the compound represented by Chemical Formula 2 with 4-chlororesinol; And reacting the compound represented by Chemical Formula 3 prepared above with the compound represented by Chemical Formula 4 to prepare a compound represented by Chemical Formula 1.
- a method of detecting hydrogen sulfide comprises the steps of: injecting a fluorescent probe for detecting hydrogen sulfide into a living body; The fluorescent probe for detecting hydrogen sulfide reacts with hydrogen sulfide in vivo to fluoresce; And confirming the fluorescence.
- the fluorescent probe capable of detecting hydrogen sulfide according to the present invention has the effect of selectively detecting hydrogen sulfide quickly and accurately.
- 1 shows absorbance of a fluorescent probe for detecting hydrogen sulfide.
- Figure 2 shows the results of the pH dependence of the fluorescent probe for detecting hydrogen sulfide prepared according to the present invention.
- Figure 3 shows the fluorescence detection results according to the absorbance of the compound represented by the formula (1) and the concentration of hydrogen sulfide.
- Figure 5 shows the results of confirming the fluorescence response of the fluorescent probe for detecting hydrogen sulfide of the present invention in the macrophages of mice.
- Figure 6 shows the results confirming the cytotoxicity of the fluorescent probe for detecting hydrogen sulfide of the present invention in HeLa cells.
- Figure 7 shows the results of confirming the fluorescence response according to the concentration of the fluorescent probe for detecting hydrogen sulfide of the present invention in mice.
- Figure 8 shows the results of confirming the fluorescence response over time in the rat.
- the term 'probe' is also referred to as 'sensor' and is defined as being capable of detecting or imaging an in vivo / external target. In general, it is used interchangeably with terms such as imaging agent, contrast agent, radiopharmaceutical.
- the fluorescent probe for detecting hydrogen sulfide of the present invention is a compound represented by the following Chemical Formula 1.
- the compound represented by Chemical Formula 1 may include an azide group to improve accessibility toward hydrogen sulfide.
- the hydrogen sulfide detection probe is a near-infrared fluorescence (NIRF), and may be selectively located in the mitochondria or cytoplasm when injected in vivo.
- NIRF near-infrared fluorescence
- the intensity of fluorescence is changed at 550 to 680 nm and 695 to 770 nm, and hydrogen sulfide can be detected by measuring the same. (See FIG. 1).
- the fluorescent probe for detecting hydrogen sulfide can preferably detect hydrogen sulfide at a penetration depth of 100 to 200 ⁇ m in vivo such as cells or tissues, and can also image in real time. Therefore, it can greatly contribute to the life science research related to hydrogen sulfide and the early diagnosis of diseases, the development of diagnostic reagents and therapeutics.
- Scheme 1 is prepared by reacting a compound represented by Formula 2 with 4-chlororesinol to a compound represented by Formula 3; And reacting the compound represented by Chemical Formula 3 prepared above with a compound represented by Chemical Formula 4 to prepare a compound represented by Chemical Formula 1.
- the compound represented by Chemical Formula 2 is a near-infrared (NIR) fluorescent dye having a higher and more stable fluorescence intensity than the clinical application dye Indocyanine green (ICG), and is a chloro-substituted cyanine dye.
- NIR near-infrared
- ICG Indocyanine green
- the compound of Formula 2 is 2- [2- [2-chloro-3- [1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene) ethylidene] -1 -Cyclohexane-1-yl] ethyl] 3,3-dimethyl-1-propylindolium iodine (2- [2- [2-Chloro-3-[(1,3-dihydro-3,3-dimethyl- 1-propyl-2H-indol-2-ylidene) ethylidene] -1-cyclohexen-1-yl] ethenyl] -3,3-dimethyl-1-propylindolium iodide), near-infrared (NIR) IR-780 iodide ( Commercially available from Aldrich ® Chemistry).
- NIR near-infrared
- an organic solvent may be added together when the 4-chlororesinol is added.
- the organic solvent is dimethylformamide (DMF), triethylamine (TEA), ethanol, diisopropyl ether, diethyl ether, dioxane, tetrahydrofuran (THF), dimethylacetamide (DMA), dimailsulfoxide (DMSO), methylene chloride (MC), acetonitrile (ACN), chlorobenzene, toluene and benzene, and preferably in dimethylformamide (DMF) and triethylamine (TEA) At least one or more may be used.
- the compound represented by Chemical Formula 1 is prepared by reacting the compound and the compound represented by Chemical Formula 4.
- the reaction may be preferably performed at 30 to 70 ° C.
- an organic solvent may be included when the compound of Chemical Formula 4 is added.
- the organic solvent is dimethylformamide (DMF), triethylamine (TEA), ethanol, diisopropyl ether, diethyl ether, dioxane, tetrahydrofuran (THF), dimethylacetamide (DMA), dimail
- the organic solvent is dimethylformamide (DMF), triethylamine (TEA), ethanol, diisopropyl ether, diethyl ether, dioxane, tetrahydrofuran (THF), dimethylacetamide (DMA), dimail
- DMSO dimethylformamide
- MC methylene chloride
- ACN acetonitrile
- chlorobenzene toluene and benzene
- THF dimethylacetamide
- THF dimethylacetamide
- dimail may include at least one or more of sulfoxide (DMSO), methylene chloride (MC), ace
- the organic solvent may further include potassium carbonate (K 2 CO 3 ).
- the organic solvent may further include a buffer.
- the buffer is preferably phosphate-buffered saline (“PBS"), sodium acetate, ammonium acetate, acetic acid, citric acid, sodium citrate, tris (hydroxymethyl) aminoethane ("tris"), N-2-hydroxy Ethylpiperazin-N'-2-ethanesulfonic acid (“HEPES”), 3- (N-morpholino) propanesulfonic acid (“MOPS”), 2- (N-morpholino) ethanesulfonic acid (“MES”) , N- (2-acetamido) iminodiacetic acid (“ADA”), piperazine-N, N'-bis (2-ethanesulfonic acid) (“PIPES”), and N- (2-acetamido) At least one of 2-aminoethanesulfonic acid (“ACES”), most preferably PBS.
- the PBS preferably has a pH of 7.4.
- (a) is 4-aminobenzyl alcohol, sodium nitrite (NaNO 2 ), sodium azide (NaN 3 ), HCl, water, (b) sulfulyl chloride (SO 2 Cl 2 ), dichloromethane (DCM).
- Hydrogen sulfide detection method of the present invention comprising the steps of injecting a fluorescent probe for detecting hydrogen sulfide prepared above in vivo;
- the fluorescent probe for detecting hydrogen sulfide reacts with hydrogen sulfide in vivo to fluoresce; And identifying the fluorescence.
- the hydrogen sulfide detection fluorescent probe represented by the following Chemical Formula 1 is characterized by fluorescence when it reacts with hydrogen sulfide to be converted into the compound represented by the following Chemical Formula 3.
- the fluorescence intensity is variable at the same time at 550 to 680nm and 695 to 770nm.
- MS Mass spectrometry
- ESI Electrospray Ionizer
- reaction was examined by thin layer chromatography (TLC) and the reaction was stopped after two hours. After extraction three times with ether, the organic phase was washed sequentially with saturated aqueous NaHCO 3 , water and brine.
- TLC thin layer chromatography
- the product was purified by silica column chromatography using ethyl acetate / n-hexane as eluent to afford the compound represented by the formula (2) as a yellow oil (1.33 g, yield 89%).
- reaction was then examined by TLC, and the reaction mixture was diluted in EtOAc and washed sequentially with saturated aqueous NaHCO 3 , water and brine.
- the organic phase was dried over MgSO 4 .
- the compound represented by Formula 1 prepared in Synthesis Example 4 was prepared using PBS buffer (10 ⁇ M, pH 7.4).
- the fluorescence spectra were examined by reacting NaHS (hydrogen sulfide source) at 37 ° C. for 30 minutes. The results are shown in Figure a).
- the compound represented by Formula 1 prepared in Synthesis Example 4 was prepared using PBS buffer (10 ⁇ M, pH 7.4). The compound was reacted with NaHS (hydrogen sulfide source) at 37 ° C. Herein, the compound represented by Chemical Formula 1 was measured for fluorescence at 720 nm. The concentration of NaHS (hydrogen sulfide source) was changed from 0 to 50 ⁇ m, and the fluorescence reaction according to the concentration was investigated. Indicated.
- the fluorescence intensity increases linearly with hydrogen sulfide from 0 to 50 ⁇ m, indicating that quantitative measurement of hydrogen sulfide concentration is possible only by measuring the fluorescence intensity.
- Analytes are shown in Table 1.
- the analyte 1 shows only the compound represented by the formula (1)
- Analyte 2 to 17 represents a mixture with the compound represented by the formula (1).
- Rat macrophages were placed in Dulbecco's modified Eagle's medium (DMEM) at 37 ° C., and cultured with 10% FBS (fetal bovine serum) in an atmosphere of 5% CO 2 and 95% air.
- DMEM Dulbecco's modified Eagle's medium
- FBS fetal bovine serum
- the compound represented by the formula (1) of 5 ⁇ m was added to the cell sample and incubated for 30 minutes.
- NaHS was added at 0, 20, 40, and 80 ⁇ m to determine the fluorescence intensity.
- CCK-8 solution (Dojindo, Japan) was added to each plate, and the cells were incubated for an additional 30 minutes.
- Balb C nude mice (15-22 g) were anesthetized by intraperitoneal injection of xylazine (10 mg / kg) and ketamine (80 mg / kg).
- rats were injected with the compound represented by the formula (1) (50 ⁇ m, 20 ⁇ L DMSO) into the abdominal cavity, and NaHS (0, 50, 100, 200 ⁇ m, 100 ⁇ L PBS) was injected into the abdominal cavity.
- mice were detected for fluorescence using IVIS Lumina II in an in vivo imaging system with a 675 nm excitation filter and a 695-770 nm luminescence filter. The result is shown in FIG.
- Balb C nude mice (15-22 g) were anesthetized by intraperitoneal injection of xylazine (10 mg / kg) and ketamine (80 mg / kg).
- rats were injected with the compound represented by the formula (50 ⁇ m, 20 ⁇ L DMSO) into the abdominal cavity, and NaHS (100 ⁇ m, 100 ⁇ L of PBS) was injected into the abdominal cavity.
- Rats were fluorescent using IVIS Lumina II in an in vivo imaging system at different times (0, 0.5, 1, 2, 3 hours) using a 675 nm excitation filter, a 695-770 nm luminescence filter and a 695-770 nm luminescence filter. Detected. The result is shown in FIG.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Combustion & Propulsion (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
La présente invention concerne une sonde fluorescente destinée à la détection de sulfure d'hydrogène et un procédé de préparation de ladite sonde fluorescente. Selon la présente invention, un capteur fluorescent apte à détecter le sulfure d'hydrogène peut détecter de manière sélective uniquement le sulfure d'hydrogène, rapidement et avec précision. De plus, la présente invention peut reconnaître, en temps réel, des phénomènes biologiques se produisant profondément dans les cellules et les tissus à l'aide d'images in vivo non invasives.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0119520 | 2016-09-19 | ||
KR1020160119520A KR20180031273A (ko) | 2016-09-19 | 2016-09-19 | 황화수소 검출용 형광 프로브 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018052243A1 true WO2018052243A1 (fr) | 2018-03-22 |
Family
ID=61620055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/010046 WO2018052243A1 (fr) | 2016-09-19 | 2017-09-13 | Sonde fluorescente destinée à la détection de sulfure d'hydrogène et procédé de préparation de ladite sonde fluorescente |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20180031273A (fr) |
WO (1) | WO2018052243A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108456197A (zh) * | 2018-03-23 | 2018-08-28 | 华南师范大学 | 用于活体检测硫化氢的光声比率纳米探针及其制备方法与应用 |
CN113092309A (zh) * | 2021-04-13 | 2021-07-09 | 福州大学 | 一种毛细管高度指示剂装置及其检测硫化氢的应用 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102051757B1 (ko) | 2018-08-16 | 2019-12-03 | 숙명여자대학교산학협력단 | 황화수소 검출용 신규 화합물 및 이를 이용한 황화수소 검출용 센서 키트 |
CN109856104A (zh) * | 2019-04-15 | 2019-06-07 | 齐齐哈尔大学 | 一种苯并吲哚半菁衍生物pH荧光探针及其制备方法 |
CN110669026B (zh) * | 2019-10-22 | 2022-04-01 | 中国科学院新疆理化技术研究所 | 一种用于检测亚硝酸盐的荧光探针分子及其制备方法 |
KR102336338B1 (ko) * | 2020-07-01 | 2021-12-09 | 대한민국 | 황화수소 검출 키트 |
KR102314070B1 (ko) * | 2020-04-28 | 2021-10-19 | 대한민국 | 황화 이온 선택성 화학센서 및 그 제조방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104946240A (zh) * | 2015-05-28 | 2015-09-30 | 中国科学院海洋研究所 | 一种硫化物荧光探针及其制备方法 |
-
2016
- 2016-09-19 KR KR1020160119520A patent/KR20180031273A/ko active Search and Examination
-
2017
- 2017-09-13 WO PCT/KR2017/010046 patent/WO2018052243A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104946240A (zh) * | 2015-05-28 | 2015-09-30 | 中国科学院海洋研究所 | 一种硫化物荧光探针及其制备方法 |
Non-Patent Citations (5)
Title |
---|
HONG, L. ET AL.: "Ln[N(SiMe3)2]3-catalyxed Cycloaddition of Terminal Alkynes to Azides Leading to 1,5-disubstituted 1,2,3-triazoles: New Mechanistic Features", CHEMICAL COMMUNICATIONS, vol. 49, no. 49, 30 April 2013 (2013-04-30), pages 5589 - 5591, XP055487238 * |
LI, Z. ET AL.: "In Vivo Imaging and Detection of Nitroreductase in Zebrafish by a New Near-infrared Fluorescence Off-on Probe", BIOSENSORS AND BIOELECTRONICS, vol. 63, 2015, pages 1 12 - 116, XP055487237, [retrieved on 20140716] * |
PARK, C. S. ET AL.: "A Near-infrared 'Turn-on' Fluorescent Probe with a Self-immolative Linker for the In Vivo Quantitative Detection and Imaging of Hydrogen Sulfide", BIOSENSORS AND BIOELECTRONICS, vol. 89, 2017, pages 919 - 926, XP055487240, [retrieved on 20160928] * |
YU , F. ET AL.: "Fluorescent Probes for Hydrogen Sulfide Detection and Bioimaging", CHEMICAL COMMUNICATIONS, vol. 50, no. 82, July 2014 (2014-07-01), pages 12234 - 12249, XP055268282 * |
ZHANG, L. ET AL.: "A Highly Selective and Sensitive Near-infrared Fluorescent Probe for Imaging of Hydrogen Sulphide in Living Cells and Mice", SCIENTIFIC REPORTS, vol. 6, 8 January 2016 (2016-01-08), pages 18868, XP055487233 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108456197A (zh) * | 2018-03-23 | 2018-08-28 | 华南师范大学 | 用于活体检测硫化氢的光声比率纳米探针及其制备方法与应用 |
CN108456197B (zh) * | 2018-03-23 | 2019-10-22 | 华南师范大学 | 用于活体检测硫化氢的光声比率纳米探针及其制备方法与应用 |
CN113092309A (zh) * | 2021-04-13 | 2021-07-09 | 福州大学 | 一种毛细管高度指示剂装置及其检测硫化氢的应用 |
CN113092309B (zh) * | 2021-04-13 | 2022-01-28 | 福州大学 | 一种毛细管高度指示剂装置及其检测硫化氢的应用 |
Also Published As
Publication number | Publication date |
---|---|
KR20180031273A (ko) | 2018-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018052243A1 (fr) | Sonde fluorescente destinée à la détection de sulfure d'hydrogène et procédé de préparation de ladite sonde fluorescente | |
CA2856946C (fr) | Pyrrolocarboxamides en tant que modulateurs de l'activite d'un recepteur orphelin gamma (rory, nr1f3) apparente au recepteur nucleaire orphelin rar et destines au traitement de maladies inflammatoires chroniques et auto-immunes | |
Wang et al. | A novel p-aminophenylthio-and cyano-substituted BODIPY as a fluorescence turn-on probe for distinguishing cysteine and homocysteine from glutathione | |
WO2015072627A1 (fr) | Sonde fluorescente à un photon et/ou à deux photons pour la détection de sulfure d'hydrogène, procédé d'imagerie du sulfure d'hydrogène l'utilisant, et son procédé de fabrication | |
EP2942352A1 (fr) | SYNTHÈSE DE RHODAMINE Si ASYMÉTRIQUE ET DE RHODOL | |
WO2017010852A1 (fr) | Composé colorant | |
WO2002051821A1 (fr) | Composes therapeutiques | |
WO2019039888A1 (fr) | Capteur d'imagerie par fluorescence en temps réel permettant de mesurer le glutathion dans un organite et son procédé de préparation | |
US9513294B2 (en) | Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing | |
WO2014181960A2 (fr) | Sonde fluorescente de détection de tyrosine kinase et son utilisation | |
Chen et al. | A novel fluorescent probe with red emission and a large Stokes shift for selective imaging of endogenous cysteine in living cells | |
WO2018062811A1 (fr) | Sonde pour la détection ou la mesure de concentration de formaldéhyde, et imagerie par fluorescence à base cinétique à deux photons et mesure de concentration de formaldéhyde dans une cellule ou un tissu utilisant celle-ci | |
WO2015020281A1 (fr) | Sonde fluorescente biphotonique de couleur variable pour détecter le sulfate d'hydrogène, son procédé de fabrication et procédé pour visualiser quantitativement le sulfate d'hydrogène in vivo qui l'utilise | |
WO2018199633A1 (fr) | Composition pharmaceutique destinée à prévenir ou à traiter des maladies liées au vieillissement, contenant un dérivé de décursine comme principe actif | |
WO2016108316A1 (fr) | Sonde fluorescente à deux photons, son procédé de préparation et procédé d'imagerie du ph l'utilisant | |
WO2016190475A1 (fr) | Composé de type thiochromène et son utilisation | |
JP2018145126A (ja) | カルボキシペプチダーゼ活性検出用蛍光プローブ | |
FR2868421A1 (fr) | Nouveaux benzothiazoles et leur utilisation comme medicaments | |
WO2021150049A1 (fr) | Nouveau composé à base de gadolinium, son procédé de production et agent de contraste pour irm contenant ledi composé | |
WO2017014601A1 (fr) | Sonde de fluorescence à base d'indolizino [3,2-c] quinoline | |
WO2016163727A9 (fr) | Sonde radioactive pour la détection de sulfure d'hydrogène | |
WO2021149900A1 (fr) | Dérivé d'adamantyle disubstitué ou son sel pharmaceutiquement acceptable, et composition pharmaceutique pour empêcher la croissance du cancer le contenant comme principe actif | |
KR102324334B1 (ko) | 황화수소 검출용 형광 프로브 및 이의 제조방법 | |
WO2021137500A1 (fr) | Capteur d'imagerie par fluorescence en temps réel pour mesurer le glutathion dans le réticulum endoplasmique et procédé faisant appel à celui-ci | |
WO2019045522A1 (fr) | Substance fluorescente à absorption monophotonique ou biphotonique à base de composé amino-sila-pyronine et son utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17851117 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17851117 Country of ref document: EP Kind code of ref document: A1 |